D2 | Impact of a family-centered care model on viral suppression among HIV-infected children in Migori, Kenya | E-poster | Impact evaluation of differentiated service delivery |
D2 | Clinical outcomes of community ART distribution: DRC's experience with the PODI+ model | E-poster | Impact evaluation of differentiated service delivery |
D2 | Cost-effectiveness of community delivery of HIV care in South Africa | E-poster | Impact evaluation of differentiated service delivery |
D2 | Does onsite HIV self-testing enhance linkage to care? A case study of HIVST Challenge Fund Project in Kenya | E-poster | Impact evaluation of differentiated service delivery |
D2 | Optimizing transitioning to differentiated service delivery key approach to achieving (UNAIDS) 90-90-90 treatment targets in Kogi State, Nigeria | E-poster | Impact evaluation of differentiated service delivery |
D2 | Differentiated prevention testing and art delivery for modified general populations and key populations in Nigeria: a documentation of best practice models | E-poster | Impact evaluation of differentiated service delivery |
D2 | Retention in care after early enrolment into differentiated service delivery models for antiretroviral treatment: a case for policy change | E-poster | Impact evaluation of differentiated service delivery |
D41 | Estimated cost-based generic prices for key ARVs and effect of COVID-19 on manufacturing costs | E-poster | Impact of COVID-19 on HIV funding |
D36 | HIV funding and access to treatment in sub-Saharan Africa | E-poster | Impact of donor agencies’ policies and international financing initiatives |
D36 | FY19-20 local vs. international PEPFAR prime partner performance | E-poster | Impact of donor agencies’ policies and international financing initiatives |